Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour

This publication has 15 references indexed in Scilit:

• Discordance between core needle biopsy (CNB) and excisional biopsy (EB) for estrogen receptor (ER), progesterone receptor (PgR) and HER2 status in early breast cancer (EBC)
  Annals of Oncology, 2009
• The accuracy of preoperative core biopsy in determining histologic grade, hormone receptors, and human epidermal growth factor receptor 2 status in invasive breast cancer
  The American Journal of Surgery, 2009
• Surgical specimen can be replaced by core samples in assessment of ER, PR and HER-2 for invasive breast cancer
  Acta Oncologica, 2008
• The reliability of assessment of oestrogen receptor expression on needle core biopsy specimens of invasive carcinomas of the breast
  Journal of Clinical Pathology, 2006
• Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
  The Breast, 2006
• Biopathologic profile of breast cancer core biopsy: is it always a valid method?
  Cancer Letters, 2005
• Core biopsy is accurate in determining the hormone receptor status of early breast cancer
  The American Journal of Surgery, 2004
• Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer
  Wiener klinische Wochenschrift, 2004
• Diagnostic accuracy of needle-localized open breast biopsy for impalpable breast disease
  British Journal of Surgery, 2000
• Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.
  Journal of Clinical Pathology, 1997